TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Percentage of space explored
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle Elasticity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Muscle Tension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Responder rate based on the Galderma Chin Retrusion Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incremental validity of the new ABDC scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Study eligibility
Endpoint domain: Mortality/survival
Primary endpoint: Composite complete remission (CRc)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reflective functioning
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Sense of competence in parenting
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Instrumental assessment of turn fluency during rapid turns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Timed Up and Go Test: dual-task performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Experiencing Influenza-like Illness (ILI)
Endpoint domain: Adverse events/effects
Primary endpoint: changes in peak oxygen consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in 5 km time trial
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in muscle glycogen content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Sleep events measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: Differential protein levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Somatic Mutations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Methylation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum tolerated dose of [225Ac]-FPI-2068 and FPI-2053
Endpoint domain: Adverse events/effects
Primary endpoint: Anthrogenic Muscle Inhibition of Vastus Medialis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Positive sperm retrieval
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Johnsen score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Sperm vials stored
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Composite metabolic endpoint
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Palm-to-finger distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: The Australian / Canadian Osteoarthritis Hand Index (AUSCAN)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Hand Osteoarthritis Functional Index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Jamar Dynamometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Voice-Handicap Index (VHI-30)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Geometric mean titer (GMT) of antigen specific antibody titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Gross Motor Function Measure-88
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Spike in blood glucose level (hyperglycemic phase)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Duration of hypo- or hyperglycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Drop in blood glucose levels (hypoglycemic phase)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Ocular tolerability at the site of administration (cornea and conjunctiva) after last instillation (1 day)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ocular tolerability at the site of administration (cornea and conjunctiva) after last instillation (7 days)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Determination of the maximum Plasma Concentration [Cmax]
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Determination of the Area Under the Curve of plasma concentrations until the last extraction time [AUT 0-t]
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gastric volume (Perlas equation)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Gastric volume (Roukhomovsky equation)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Area under the semaglutide milk concentration-time curve (AUC0-24h,sema,D10,milk)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the salcaprozate sodium milk concentration-time curve (AUC0-24h,SNAC,D10,milk)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pulmonary hypertension related mortality
Endpoint domain: Mortality/survival
Primary endpoint: Evolution of the shape of the aneurysm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Prevalence of vaccination uptake
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Soluble Cluster of Differentiation 14 (sCD14)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Soluble Cluster of Differentiation 163 (sCD163)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Monocyte Chemoattractant Protein-1 (MCP-1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: frequency of success
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Antimicrobial therapy duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient Competency
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Use of chemotherapy within the last 30 days of life
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in patient's anxiety symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in caregiver's anxiety symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time to Reepithelization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Visibility of the venous network
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Higher scores on a Likert-style questionnaire for content knowledge learning objectives
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Scores on Likert-style questionnaire to evaluate behavior change around air quality
Endpoint domain: Life impact
Endpoint subdomain: Behavioral functioning
Primary endpoint: Change in student exposure to air pollution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tpCR (ypT0/is ypN0)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Molecular imaging markers of inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of SABR successfully delivered in one fraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of patients demonstrating tolerability
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Forgotten Joint Score-12 (FJS-12)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in modified Patient Enablement Instrument-2 (Mod-PEI-2)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Score of Questionnaire on knowledge, attitudes and practices
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Narrative identity
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Serum copper (Cu) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Optimal biological dose (OBD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Phenotypic/functional biomarkers of aging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intubations
Endpoint domain: Adverse events/effects
Primary endpoint: Neurologic Integrity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Neuropsychological Functioning
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Detection of anogenital HPV-related cancers and HSIL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Compound adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Area Under the Curve from Time Zero to end of dosing interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absolute neutrophil counts (ANC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in Empowerment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Coping Skills Pre-assessment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Coping Skills Post-assessment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Effectiveness of treatment for cutaneous warts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Successful rate of reversion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disease activity at 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neuromuscular performance during countermovement jumps
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration Versus Time Curve (AUC) of metformin and atorvastatin/warfarin and digoxin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration Versus Time Curve (AUC) of ethinylestradiol and levonorgestrel
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Past-year medically treated suicide attempt
Endpoint domain: Mortality/survival
Primary endpoint: Suicide Severity and Behaviors using Computerized Adaptive Test Suicide Scale (CAT-SS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Bleeding on primary dressing removal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Drop out rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Frequency of health care use
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: electronic Frailty Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brain Activation to Painful Stimulation Difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Resting-state Functional Connectivity Difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Major VTE prevention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Episodes of Major Bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With at Least One Serious Treatment-Emergent Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Tolerability of the IMP
Endpoint domain: Adverse events/effects
Primary endpoint: Safety of the IMP
Endpoint domain: Adverse events/effects
Primary endpoint: Wellness level
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Pain catastrophizing level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Patients' level of understanding of communication tools
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Acute Lumen Gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent of participants with an unfavorable outcome
Endpoint domain: Adverse events/effects
Primary endpoint: Health Questionnaire (EQ-5D-5L)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Satisfaction of simulated patients and operators
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Male reproductive health
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Cost of explant, intermediate care and re-implantation of device
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Participants with Improved Physical Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Score on Gross Motor Function Measure (GMFM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Score on Pediatric Evaluation of Disability Inventory (PEDI)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of Participants With Acute kidney injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Proportion of subjects with resolution of index MDRO colonization of the gut
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Frequency of adverse events of special interest (AESIs)
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of medically attended adverse events (MAAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Overground Self-selected Walking Speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: T Lymphocyte Count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: T Lymphocyte Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence rate of graft versus host disease (GvHD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in overall survival (OS)
Endpoint domain: Mortality/survival
Primary endpoint: cervical lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of participants completing surveys and interviews
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of cases of skin NTD and other skin conditions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Rate of all causes death
Endpoint domain: Mortality/survival
Primary endpoint: Sensitivity, specificity and area under the ROC curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Freedom from major device related adverse events (MADE)
Endpoint domain: Adverse events/effects
Primary endpoint: Freedom from target lesion reintervention due to recurrence of CRS
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of advance care planning notes
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Patient readmission rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Peak O2 intake during test exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cardiac output during test exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: AUC0-∞ of NNC0194-0499
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skin Temperature Increase From Baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Improvement in thrombogenicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Global transient mood as measured by PANAS-X
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean change from baseline in ETDRS BCVA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Pharmacodynamic assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of perioperative follow-up
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Changes of the Canadian Occupational Performance Measure
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Changes of the Instrumental Activities of Daily Living-3 Dimensions
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Changes of the Mini Mental State Examination-2nd edition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Prevalence of post-traumatic stress disorder
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Postoperative incidence of serious adverse events related to GRANITE
Endpoint domain: Adverse events/effects
Primary endpoint: Postoperative incidence of SI joint pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in Quality of Life PROs
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in spindles after effective TES-TI intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in minutes scored as REM sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in sleep quality and mood
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: invasive breathing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change of RV end-systolic volume index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Problem Gambling Severity Index (PGSI) Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number and Duration of FOG episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Unstimulated Saliva Flow Rate (USFR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Global Impression of Change (CGI-C) score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Pediatric Anxiety Rating Scale (PARS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in SARS-CoV-2 IgG Titer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: risk of MPNST formation
Endpoint domain: Mortality/survival
Primary endpoint: Number of patient-triggered Apple Watch ECGs recorded
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of medical providers accessing Apple Watch data
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Apple Watch ECGs of acceptable quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Red blood cell lipid composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Skeletal muscle lipid composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Adipose tissue lipid composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percent initial weight loss at 24 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Safety of bi-4SCARCD19/22 T cells
Endpoint domain: Adverse events/effects
Primary endpoint: Recurrence after colorectal EMR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Rate of Genetic Counseling and Testing Uptake
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Condition of the newborn
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Size at birth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients receiving services
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Educational content and format acceptability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Lab Site accessibility/ Participant Convenience
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Scheduling of Lab assessments
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Increased distance on Six Minute Walk Test (6MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wheal Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Gas exchange parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Hemodynamic and vital parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Lung mechanics parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of Participants that Die Within One Year
Endpoint domain: Mortality/survival